Valiant Navion™ VNMF2828C97TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMF2828C97TU VAL NAV FF · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00763000100575), received between Jul 20, 2020 and Mar 1, 2023 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Material Deformation” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Material Deformation2
- Leak/Splash1
- Premature Activation1
Patient problems
- Aneurysm1
- No Consequences Or Impact To Patient1
- Obstruction/Occlusion1
- Thrombosis/Thrombus1
- Vascular Dissection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryMar 1, 2023Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC ANEURYSM. IT WAS REPORTED APPROXIMATELY 13 MONTHS POST THE INDEX PROCEDURE, FOLLOW UP CT IDENTIFIED A TYPE IB ENDOLEAK LOCATED APPROXIMATELY 30MM ABOVE THE CELIAC ACCESS. INTERVENTION WAS COMPLETED WHERE A NON MDT STENT GRAFT WAS IMPLANTED IN THE DISTAL DESCENDING THORACIC AORTA. COMPLETION ANGIOGRAM SHOWED EXCELLENT SEALING OF THE GRAFT AND A COMPLETE SEAL OF THE ENDOLEAK. IT WAS REPORTED APPROXIMATELY 2 YEARS POST THE INDEX PROCEDURE, THE PATIENT COMPLAINED OF PAIN AT REST IN THE LEFT LOWER EXTREMITY AND PAIN WITH WALKING. FOLLOW UP DETERMINED THE PATIENT HAD AN IN-FLOW ISSUE PRESUMABLY FROM THE PATCH CLOSURE. THE PHYSICIAN ELECTED TO COMPLETE AN ANGIOGRAM WITH REVASCULARIZATION ON THIS DATE. A 8X100MM SELF-EXPANDING STENT WAS PLACED UP TO THE ILIAC BIFURCATION ON THE LEFT. THE PATIENT STATUS HAS BEEN REPORTED AS DOING WELL POST THIS PROCEDURE. THE CAUSE OF THE TYPE IB ENDOLEAK WAS NOT PROVIDED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Obstruction/Occlusion
MAUDE report 16458177 ↗MalfunctionNov 10, 2022Material Deformation; Material Deformation
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING REINTERVENTION FOR A PRIOR AORTIC REPAIR. IT WAS REPORTED CORE LAB REVIEW OF CT IMAGING FROM 01-OCT-2021 & 13-OCT-2021 NOTED AN OBSERVATION OF THE PRESENCE OF INTRALUMINAL THROMBUS AND NARROWING OF DEVICE AT THE PROXIMAL END JUST DISTAL TO AORTIC BRANCH VESSELS. NO ENDOLEAK, STENT RING ENLARGEMENT OR AORTIC ENLARGEMENT WAS OBSERVED. THE IMAGING WAS NOTED AS NE FOR FRACTURE DUE TO SCAN QUALITY AND DEVICE OVERLAPS. THE CAUSE OF THE INTRALUMINAL THROMBUS AND NARROWING IS UNDERMINED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: Thrombosis/Thrombus
MAUDE report 15770388 ↗InjuryNov 2, 2022Material Deformation; Material Deformation
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN AN UNKNOWN ENDOVASCULAR PROCEDURE. IT WAS REPORTED ON THE DATE OF THE CT, AORTIC ENLARGEMENT WAS IDENTIFIED. THE RADIOLOGIST REVIEWED THE IMAGING AND NOTED A NEW FOCAL TYPE B DISSECTION OF THE PROXIMAL DESCENDING THORACIC AORTA WITHIN THE ENDOGRAFT. IT WAS REPORTED THAT IT SEEMS HIGHLY PROBABLE THAT THE LONGITUDINAL SEAM HAS GIVEN WAY ON THE STENT GRAFT IMPLANT. PER THE PHYSICIAN THE CAUSE IF THE EVENT IS A DEVICE FAILURE. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Aneurysm; Vascular Dissection
MAUDE report 15714605 ↗MalfunctionJul 20, 2020Premature Activation; Premature Activation
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A 60MM THORACIC AORTIC ANEURYSM. IT WAS REPORTED THAT DURING THE INDEX PROCEDURE, THAT THE FREE FLOW PROXIMAL STENT OF THE DEVICE DEPLOYED AUTOMATICALLY DURING THE UNSHEATHING OF THE GRAFT COVER. IT WAS STATED THE TIP CAPTURE MECHANISM WAS NOT INTERFERED WITH PRE- DEPLOYMENT AND REMAINED THE LOCKED POSITION THROUGHOUT DEPLOYMENT AND THERE WAS NO ATYPICAL RESISTANCE DURING THE DELIVERY NOTED. THERE WAS NO CONSEQUENCES TO THE DELIVERY OR ACCURATE PLACEMENT OF THE DEVICE. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT CAN NOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10294686 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page